 |
 |

Effects of Carbamazepine on Dopamine- and Serotonin-Mediated Neuroendocrine Responses
Martin Elphick, MRCPsych;
Jing-Duan Yang, MD;
Philip J. Cowen, MRCPsych
Arch Gen Psychiatry. 1990;47(2):135-140.
Abstract
Neuroendocrine testing was carried out in seven male volunteers before and at the end of a 10-day course of carbamazepine (up to 700 mg daily). After carbamazepine treatment, the prolactin response to intravenous administration of the serotonin precursor tryptophan (5 g) was significantly enhanced, but there was no change in basal plasma tryptophan level or in tryptophan disposition after infusion. The prolactin response to intravenous protirelin (6.25 µg) was unaltered. Carbamazepine treatment also produced an increase in the growth hormone response to subcutaneous administration of the dopamine agonist apomorphine hydrochloride (5 µg/kg). These data suggest that carbamazepine may alter brain serotonin and dopamine function in humans. Such effects could be involved in the therapeutic properties of carbamazepine in affective disorder.
Author Affiliations
From the Oxford University Department of Psychiatry and Medical Research Council Clinical Pharmacology Unit, Littlemore Hospital, Oxford, England. Dr Elphick was Oxford Regional Health Authority Fellow in Clinical Psychopharmacology.
Footnotes
Accepted for publication June 30, 1989.
Reprint requests to Oxford University Department of Psychiatry and MRC Clinical Pharmacology Unit, Littlemore Hospital, Oxford OX4 4XN, England (Dr Cowen).
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Carbamazepine Treatment in Patients Discontinuing Long-term Benzodiazepine Therapy: Effects on Withdrawal Severity and Outcome
Schweizer et al.
Arch Gen Psychiatry 1991;48:448-452.
ABSTRACT
|